Cetera Advisors’s Braskem BAK Stock Holding History

Cetera Advisors’s Portfolio BAK Stock Details BAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-47,306	Closed	-$676K	–	1344
2022 Q2	$676K	Buy	47,306 +36,869	+353%	+$631K	0.02%	721
2022 Q1	$195K	Buy	+10,437	New	+$198K	﹤0.01%	1310

Other funds holding BAK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Cetera Advisors's BAK Position: Q3 2022 in Review

Cetera Advisors sold out of Braskem (BAK) in Q3 2022, closing a stake of 47,306 shares — an estimated $676K sold.

Cetera Advisors first reported a position in BAK in Q1 2022 and held it in 2 quarters. The position peaked at $676K in Q2 2022. 45 funds tracked by Wall St. Rank hold BAK as of Q3 2022.

Cetera Advisors reported no remaining Braskem position as of Q3 2022 after selling out during the quarter.
Cetera Advisors sold 47,306 Braskem shares in Q3 2022, an estimated $676K.
Cetera Advisors first reported a position in Braskem in Q1 2022 and held it in 2 quarters.
Cetera Advisors's Braskem position peaked at $676K in Q2 2022.
45 funds tracked by Wall St. Rank held Braskem as of Q3 2022.

Based on Cetera Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.